Logo image of VRAR

GLIMPSE GROUP INC/THE (VRAR) Stock Fundamental Analysis

NASDAQ:VRAR - Nasdaq - US37892C1062 - Common Stock - Currency: USD

1.14  -0.08 (-6.56%)

After market: 1.17 +0.03 (+2.63%)

Fundamental Rating

3

VRAR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 81 industry peers in the IT Services industry. The financial health of VRAR is average, but there are quite some concerns on its profitability. While showing a medium growth rate, VRAR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VRAR had negative earnings in the past year.
In the past year VRAR has reported a negative cash flow from operations.
VRAR had negative earnings in each of the past 5 years.
In the past 5 years VRAR always reported negative operating cash flow.
VRAR Yearly Net Income VS EBIT VS OCF VS FCFVRAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

VRAR's Return On Assets of -29.32% is on the low side compared to the rest of the industry. VRAR is outperformed by 84.15% of its industry peers.
The Return On Equity of VRAR (-36.41%) is worse than 64.63% of its industry peers.
Industry RankSector Rank
ROA -29.32%
ROE -36.41%
ROIC N/A
ROA(3y)-58.09%
ROA(5y)-122.58%
ROE(3y)-110.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VRAR Yearly ROA, ROE, ROICVRAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

VRAR has a Gross Margin of 70.06%. This is amongst the best in the industry. VRAR outperforms 87.80% of its industry peers.
VRAR's Gross Margin has improved in the last couple of years.
VRAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y3.11%
VRAR Yearly Profit, Operating, Gross MarginsVRAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

6

2. Health

2.1 Basic Checks

VRAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRAR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VRAR has more shares outstanding
VRAR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VRAR Yearly Shares OutstandingVRAR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
VRAR Yearly Total Debt VS Total AssetsVRAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

VRAR has an Altman-Z score of -0.62. This is a bad value and indicates that VRAR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VRAR (-0.62) is worse than 82.93% of its industry peers.
VRAR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACC9.2%
VRAR Yearly LT Debt VS Equity VS FCFVRAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 2.54 indicates that VRAR has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.54, VRAR is doing good in the industry, outperforming 78.05% of the companies in the same industry.
A Quick Ratio of 2.54 indicates that VRAR has no problem at all paying its short term obligations.
VRAR has a better Quick ratio (2.54) than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.54
VRAR Yearly Current Assets VS Current LiabilitesVRAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.31% over the past year.
The Revenue for VRAR has decreased by -21.52% in the past year. This is quite bad
The Revenue has been growing by 55.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)79.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.44%
Revenue 1Y (TTM)-21.52%
Revenue growth 3Y37.05%
Revenue growth 5Y55.13%
Sales Q2Q%52.61%

3.2 Future

The Earnings Per Share is expected to grow by 37.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, VRAR will show a quite strong growth in Revenue. The Revenue will grow by 14.83% on average per year.
EPS Next Y77.01%
EPS Next 2Y37.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.1%
Revenue Next 2Y14.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VRAR Yearly Revenue VS EstimatesVRAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
VRAR Yearly EPS VS EstimatesVRAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VRAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRAR Price Earnings VS Forward Price EarningsVRAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRAR Per share dataVRAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

VRAR's earnings are expected to grow with 37.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.3%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VRAR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLIMPSE GROUP INC/THE

NASDAQ:VRAR (4/25/2025, 8:00:01 PM)

After market: 1.17 +0.03 (+2.63%)

1.14

-0.08 (-6.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-19 2025-05-19/amc
Inst Owners11.24%
Inst Owner Change0%
Ins Owners15.56%
Ins Owner Change1%
Market Cap23.99M
Analysts82.86
Price Target2.67 (134.21%)
Short Float %1.23%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.05%
Min EPS beat(2)18.3%
Max EPS beat(2)109.8%
EPS beat(4)3
Avg EPS beat(4)34.23%
Min EPS beat(4)-22.55%
Max EPS beat(4)109.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.93%
Min Revenue beat(2)-8.07%
Max Revenue beat(2)0.22%
Revenue beat(4)1
Avg Revenue beat(4)-8.67%
Min Revenue beat(4)-15.33%
Max Revenue beat(4)0.22%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-43.9%
PT rev (3m)-1.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)-700%
EPS NY rev (3m)46.67%
Revenue NQ rev (1m)-9.09%
Revenue NQ rev (3m)-53.12%
Revenue NY rev (1m)-23.33%
Revenue NY rev (3m)-23.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.6
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 3.53
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.44
BVpS0.85
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.32%
ROE -36.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.06%
FCFM N/A
ROA(3y)-58.09%
ROA(5y)-122.58%
ROE(3y)-110.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y3.11%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.38%
Cap/Sales 0.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 2.54
Altman-Z -0.62
F-Score5
WACC9.2%
ROIC/WACCN/A
Cap/Depr(3y)15.4%
Cap/Depr(5y)59.24%
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.44%
EPS Next Y77.01%
EPS Next 2Y37.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.52%
Revenue growth 3Y37.05%
Revenue growth 5Y55.13%
Sales Q2Q%52.61%
Revenue Next Year1.1%
Revenue Next 2Y14.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.79%
OCF growth 3YN/A
OCF growth 5YN/A